NEW YORK (GenomeWeb) - Affymetrix today reported a slight decrease year over year in its third quarter reported revenues.

For the three months ended Sept. 30, Affymetrix's total revenues dipped less than one percent to $86.5 million from $87.1 million in the prior-year period. On a constant currency basis, its revenues increased almost 4 percent year over year, and beat the average Wall Street estimate of $87.5 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.